BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 29
• 30

• Press Releases

  Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease

  December 10, 2025

   · 

  1 min read
• Press Releases

  Modular Medical Announces Proposed Public Offering

  December 10, 2025

   · 

  4 min read
• Press Releases

  Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy

  December 10, 2025

   · 

  5 min read
• Press Releases

  Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama

  December 10, 2025

   · 

  7 min read
• Press Releases

  Picard Celebrates Patient Living a World-Record of Over Eight Years with the SynCardia Total Artificial Heart

  December 10, 2025

   · 

  4 min read
• Press Releases

  Terns Announces Proposed Public Offering

  December 10, 2025

   · 

  5 min read
• Press Releases

  1 in 4 metastatic breast cancer patients treated with Novartis Kisqali® remain progression-free beyond 4 years

  December 10, 2025

   · 

  13 min read
• Press Releases

  Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada

  December 10, 2025

   · 

  7 min read
• Press Releases

  ONL Therapeutics Announces Publication of Data from Phase 1b Study of Xelafaslatide, an Investigational Therapy for Geographic Atrophy, in Ophthalmology Science

  December 10, 2025

   · 

  4 min read
• Press Releases

  Saol Therapeutics Has Been Granted a Type A Meeting with the FDA to Determine the Path Forward for SL1009 in Pyruvate Dehydrogenase Complex Deficiency (PDCD)

  December 10, 2025

   · 

  3 min read